Inhalation Sciences: Full enrolment reached in landmark PreciseInhale clinical trial
(Stockholm, Sweden, June 22, 2021) Full enrolment has been reached, on schedule, in ISAB’s clinical trial of its aerosol generating system PreciseInhale[®]- with all 12 patients recruited. CEO Manoush Masarrat: “Clinical validation would make PreciseInhale[®] the first aerosol generation platform that can be used from drug discovery, through preclinical studies, all the way to phase I clinical trials - a major milestone that could open up significant new markets.”The first 4 healthy volunteer patients were enrolled on Wednesday 16 June. Now all 12 patients have been enrolled onto the study,